IMMUNITYBIO, INC. Increase (Decrease) in Deferred Revenue
IMMUNITYBIO, INC. (IBRX) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-03-25
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for the quarter ending 2019-12-31 was $0.00.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for the quarter ending 2019-09-30 was $0.00.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for the quarter ending 2019-06-30 was $0.00.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for the quarter ending 2019-03-31 was $0.00.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for fiscal 2019 was $0.00.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for fiscal 2018 was -$508.00K, a 142.30% decline from fiscal 2017.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for fiscal 2017 was $1.20M, a 31.53% decline from fiscal 2016.
- IMMUNITYBIO, INC. increase (decrease) in deferred revenue for fiscal 2016 was $1.75M, a 137.99% increase from fiscal 2015.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $0.00 derived: sum of 2 quarters · filed 2020-03-25 | $0.00 derived: sum of 3 quarters · filed 2020-03-25 | $0.00 10-K · filed 2020-03-25 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | -$138.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | -$138.00K derived: sum of 3 quarters · filed 2020-03-25 | -$269.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | -$138.00K derived: sum of 2 quarters · filed 2020-03-25 | -$269.00K derived: sum of 3 quarters · filed 2020-03-25 | -$390.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$269.00K derived: sum of 2 quarters · filed 2020-03-25 | -$390.00K derived: sum of 3 quarters · filed 2020-03-25 | -$508.00K 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | -$131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$252.00K derived: sum of 2 quarters · filed 2019-11-05 | -$370.00K 10-Q · filed 2019-11-05 | -$491.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-06-30 | -$121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$239.00K 10-Q · filed 2019-08-06 | -$360.00K derived: sum of 3 quarters · filed 2020-03-25 | -$465.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-03-31 | -$118.00K 10-Q · filed 2019-05-08 | -$239.00K derived: sum of 2 quarters · filed 2020-03-25 | -$344.00K derived: sum of 3 quarters · filed 2020-03-25 | $1.12M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2017-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$226.00K derived: sum of 2 quarters · filed 2020-03-25 | $1.24M derived: sum of 3 quarters · filed 2020-03-25 | $1.20M 10-K · filed 2020-03-25 | ||||
| 2017-09-30 | -$105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.36M derived: sum of 2 quarters · filed 2018-11-07 | $1.32M 10-Q · filed 2018-11-07 | $1.44M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.43M 10-Q · filed 2018-08-06 | $1.55M derived: sum of 3 quarters · filed 2019-03-13 | $2.16M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | -$40.00K 10-Q · filed 2018-05-07 | $79.00K derived: sum of 2 quarters · filed 2019-03-13 | $692.00K derived: sum of 3 quarters · filed 2019-03-13 | $1.22M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $732.00K derived: sum of 2 quarters · filed 2019-03-13 | $1.26M derived: sum of 3 quarters · filed 2019-03-13 | $1.75M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $613.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.14M derived: sum of 2 quarters · filed 2017-11-07 | $1.64M 10-Q · filed 2017-11-07 | -$15.00K 10-Q · filed 2016-11-10 | $2.48M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-06-30 | $527.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.02M 10-Q · filed 2017-08-07 | -$9.00K 10-Q · filed 2016-08-15 | $1.86M derived: sum of 3 quarters · filed 2018-03-12 | $1.86M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-03-31 | $495.00K 10-Q · filed 2017-05-08 | -$5.00K 10-Q · filed 2016-05-16 | $1.34M derived: sum of 2 quarters · filed 2018-03-12 | $1.33M derived: sum of 3 quarters · filed 2018-03-12 | $1.30M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $837.00K derived: sum of 2 quarters · filed 2018-03-12 | $801.00K derived: sum of 3 quarters · filed 2018-03-12 | $737.00K 10-K · filed 2018-03-12 | -$113.00K 10-K · filed 2016-03-30 | |||
| 2015-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$42.00K derived: sum of 2 quarters · filed 2016-11-10 | -$106.00K 10-Q · filed 2016-11-10 | -$52.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$100.00K 10-Q · filed 2016-08-15 | -$46.00K derived: sum of 3 quarters · filed 2017-03-15 | -$17.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | -$64.00K 10-Q · filed 2016-05-16 | -$10.00K derived: sum of 2 quarters · filed 2017-03-15 | $19.00K derived: sum of 3 quarters · filed 2017-03-15 | |||||
| 2014-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $83.00K derived: sum of 2 quarters · filed 2017-03-15 | -$52.00K 10-K · filed 2017-03-15 | |||||
| 2014-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$106.00K 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | -$135.00K 10-Q · filed 2015-09-10 | |||||||
| 2013-12-31 | -$75.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |